Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

NCT03983018 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia Spectrum and Other Psychotic Disorders
Treatment-resistant Schizophrenia

Interventions

DRUG: Rituximab

Sponsor

Region Örebro County

Collaborators

[object Object]